Aprender los procesos de animación 3D, concept art, producción y fondos mediante la experiencia adquirida en el desarrollo del cineminuto animado Yo yo de Piro & Nola

136 páginasLa presente tesis tiene la intención de exponer los procesos creativos, retos, conflictos y aprendizajes adquiridos a lo largo de las distintas etapas de preproducción, producción y postproducción, en los cargos animación, fondos, concept art y producción; fases por las cuales se atravesó durante el desarrollo del producto audiovisual animado por computadora Piro & Nola. Recurriendo a la mezcla de distintas técnicas de animación (2D y 3D), el producto consta de dos episodios de un minuto de duración cada uno. Esto con la finalidad de crear una guía para las personas interesadas en la creación de contenido audiovisual animado en 3D, más específicamente, en Colombia. Este proyecto hace parte de una serie animada que sigue las aventuras de dos niños llamados Piro & Nola mientras juegan con juguetes típicos colombianos (balero, yo-yo, golosa, trompo, piedra, papel y tijeras, etc.), en donde los personajes se embarcan en aventuras a gran escala utilizando su imaginación cada vez que juegan. Este corto tiene la intención de ser un tráiler para vender la serie con miras a ofertarse en formatos más largos con recursos monetarios y/o mercados de animación. Es por esto que se producen, dos capítulos: Yo-yo y Rayuela. La presente tesis se enfoca en la realización del episodio Yo-yo. Este proyecto, al mismo tiempo, permite que un equipo de jóvenes creadores pueda capacitarse en el campo de la animación. En el documento, se encuentran consignados distintos referentes e inspiraciones que influyeron en la toma de decisiones creativas y, por consiguiente, la creación del producto audiovisual. No obstante, este trabajo también recoge el material realizado por parte de los departamentos involucrados incluyendo las distintas versiones, propuestas, ideas y/o prototipos que en algún momento fueron planteados para el producto final.Comunicación Audiovisual y MultimediosComunicador Audiovisual y Multimedio

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

The original version of this article unfortunately contained a mistake

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Monismo y dualismo: Apuntes de jurisprudencia sobre el control constitucional de los tratados en Colombia

Entre las principales teorías del derecho internacional encontramos el dualismo y el monismo. La primera, entiende el derecho interno (nacional) y el derecho internacional como dos sistemas jurídicos que coexisten de manera separada, por lo que no se relacionan entre sí. Por otro lado, el monismo parte de la idea que los sistemas se cruzan. Al hacer parte de un mismo sistema, hay dos variantes de esta teoría. El monismo moderado con primacía del derecho internacional considera que este es superior que el derecho nacional. Por otro lado, el monismo moderado interno plantea lo opuesto. Cuales quiera que sea la teoría monista adoptada, busca que el "inferior" se adecue a sus principios. A partir del estudio del fenómeno de control constitucional en Colombia se evidencia la aplicación de las distintas teorías. En ese sentido, la obligatoriedad y eficacia del derecho internacional es cuestionada al ser contrastado con el derecho interno, particularmente con la Constitución de 1991. En Colombia, los tratados son incorporados mediante las leyes. Gracias al artículo 241 de la Constitución, la Corte Constitucional está facultada para analizar las leyes aprobatorias de tratado y contrastarlos con la Constitución. Aunque hoy en día el control constitucional es posterior a la ley aprobatoria y previo a que el ejecutivo ratifique un tratado, en los orígenes de esta figura surgió la polémica de los tratados con inconstitucionalidad sobreviniente. En ese sentido, los compromisos internacionales adoptados por Colombia antes del 91 pueden ser contrarios a la Constitución. Tal situación pone en entre dicho el principio de pacta sunt servanda. Sin embargo, como se estudiará a continuación, han sido diversos escenarios en los cuales se estudió la constitucionalidad de los tratados internacionales variando entre el dualismo y el monismo moderado. Con eso presente, en este documento, encontrarán nueve sentencias hito de control constitucional de los tratados. En cada una de ellas se analizará cómo llego la norma a ser estudiada por la Corte, los argumentos para su inconstitucionalidad, las consideraciones de la Corte, la teoría que aplicó y un breve comentario sobre la decisión y sus implicaciones

Constituciones latinoamericanas 2022. Reporte de cláusulas de control constitucional difuso y concentrado

El reporte 2022 realizado por los estudiantes del curso “constitución, convencionalidad y derecho internacional” del pregrado en Derecho de la Facultad de Jurisprudencia de la Universidad del Rosario, presenta el estudio de las formas de control constitucional, a través de las cláusulas constitucionales de veintiséis (26) países de América Latina, especialmente en lo que respecta a su cláusula de supremacía constitucional; seguido de un ejemplo analizado de una cláusula en su correspondiente constitución que desarrolle la noción de “control difuso y abstracto” y “control concreto y concentrado”

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. Methods: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping riociguat treatment. Primary safety outcomes were adverse events (AEs) and serious adverse events (SAEs) coded using Medical Dictionary for Regulatory Activities preferred terms and System Organ Classes version 21.0, collected during routine clinic visits and collated via case report forms. Results: In total, 956 patients with CTEPH were included in the analysis. The most common AEs in these patients were peripheral edema/edema (11.7%), dizziness (7.5%), right ventricular (RV)/cardiac failure (7.7%), and pneumonia (5.0%). The most common SAEs were RV/cardiac failure (7.4%), pneumonia (4.1%), dyspnea (3.6%), and syncope (2.5%). Exposure-adjusted rates of hemoptysis/pulmonary hemorrhage and hypotension were low and comparable to those in the long-term extension study of riociguat (Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase-Stimulator Trial [CHEST-2]). Conclusion: Data from EXPERT show that in patients with CTEPH, the safety of riociguat in routine practice was consistent with the known safety profile of the drug, and no new safety concerns were identified

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

International audienc